| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |